PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Sep-2024 Ensysce Biosciences Presenting at Upcoming Meetings AccessWire
24-Sep-2024 Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical Study of ENA-001 to Be Conducted in the United States AccessWire
24-Sep-2024 Cloud Storage Security Names Kevin Hunt as Chief Technology Officer AccessWire
24-Sep-2024 CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace AccessWire
24-Sep-2024 Longwood Healthcare Leaders' Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research Newswire
24-Sep-2024 Interactive Strength Inc. (Nasdaq:TRNR) Successfully Passes EU Compliance for CLMBR and will Start Fulfilling European and UK Orders Immediately AccessWire
24-Sep-2024 Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology AccessWire
24-Sep-2024 Longwood Healthcare Leaders' Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research AccessWire
24-Sep-2024 Alithea Genomics Secures Loan from Swiss Technology Fund Alithea Genomics
24-Sep-2024 ZEO ScientifiX is Moving Toward Its Goal of Transforming Healthcare Through Leading-Edge Research Newswire
24-Sep-2024 Bio-Sourcing secures European Innovation Council (EIC) Accelerator funding to bridge the biomanufacturing gap and make biotherapeutics more available and affordable Andrew Lloyd Associates
24-Sep-2024 Bioz and Boston BioProducts Introduce Advanced Badges and Content Hub to Transform Research Discovery AccessWire
24-Sep-2024 Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs Mabylon AG
24-Sep-2024 Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops Marinomed Biotech AG
23-Sep-2024 Cenna Biosciences Receives NIH NIA Phase II SBIR Award for the Early Clinical Development of Nubytide TM, a First-in-Class, Disease-Modifying Peptide Drug for the Prevention and Treatment of Alzheimer’s Disease AccessWire
23-Sep-2024 OrtoWay-US Inc. Announces Granting of U.S. Patent for OrtoWell(R) Distractor System for Spinal Surgery Corpectomy AccessWire
23-Sep-2024 Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins AccessWire
23-Sep-2024 Integrated DNA Technologies Unveils New Lymphoma Panel to Enhance Blood Cancer Research Integrated DNA Technologies
23-Sep-2024 Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine Vicebio Ltd
23-Sep-2024 Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Sanofi